China Universal Asset Management Company’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
S
China Universal Asset Management Company's LKFT Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9% in Q2 2026, selling an estimated $6.76K and leaving 2,393 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #440.
China Universal Asset Management Company first reported a position in LKFT in Q3 2022 and has held it in 16 quarters since. The position peaked at $121K in Q1 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- China Universal Asset Management Company held 2,393 shares of Lakefront Biotherapeutics American Depositary Shares worth $71.7K as of Q2 2026.
- China Universal Asset Management Company sold 238 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $6.76K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #440 holding.
- China Universal Asset Management Company first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Lakefront Biotherapeutics American Depositary Shares position peaked at $121K in Q1 2024.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.